Evidence for therapeutic drug monitoring of targeted anticancer therapies. [electronic resource]
Producer: 20130117Description: 4017-25 p. digitalISSN:- 1527-7755
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Area Under Curve
- Benzamides
- Benzenesulfonates -- administration & dosage
- Cetuximab
- Dasatinib
- Drug Monitoring -- methods
- Everolimus
- Evidence-Based Medicine
- Half-Life
- Humans
- Imatinib Mesylate
- Indoles -- administration & dosage
- Injections, Intravenous
- Molecular Targeted Therapy -- methods
- Neoplasms -- blood
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Piperazines -- administration & dosage
- Pyridines -- administration & dosage
- Pyrimidines -- administration & dosage
- Pyrroles -- administration & dosage
- Rituximab
- Sirolimus -- administration & dosage
- Sorafenib
- Sunitinib
- Thiazoles -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.